Washington State Implements Toxic-Free Cosmetics Act
Washington State is set to enact the Toxic-Free Cosmetics Act, commencing January 1, 2025, bringing forth significant implications for businesses operating in the cosmetic industry. This legislative measure aims to regulate the manufacture, distribution, and sale of cosmetic products containing nine specified chemicals or chemical classes. It is essential for businesses to familiarise themselves with the provisions of this act to ensure compliance and mitigate any potential impact on their operations.
The act adopts a comprehensive definition of cosmetics consistent with the FDA's classification, encompassing a wide array of products, including makeup, perfume, shampoo, deodorant, and various personal care items. The focus of the legislation is on restricting chemicals deemed harmful to human health and the environment, reflecting a growing concern for consumer safety and product compliance within the industry.
Key chemicals and chemical classes restricted under the Toxic-Free Cosmetics Act include:
- Ortho-phthalates
- Perfluoroalkyl and polyfluoroalkyl substances (PFAS)
- Formaldehyde-releasing chemicals
- Ethylene glycol
- Mercury compounds
- Triclosan
- M-phenylenediamine, o-phenylenediamine, and lead compounds.
Understanding these restrictions and their implications is crucial for businesses to navigate the regulatory landscape effectively.
To aid businesses in compliance efforts, Washington State is offering a technical assistance program and engaging stakeholders in the rule-making process. Businesses are encouraged to subscribe to the email list for updates and participate in providing feedback to shape the implementation of the Toxic-Free Cosmetics Act. Additional information and resources can be accessed through the state's official website or by contacting the designated email address, ToxicFreeCosmetics@ecy.wa.gov.
Japan Reports on Recalled Cosmetics and Quasi-drugs in 2023
The Japan Pharmaceuticals and Medical Devices Agency (PMDA) reported a total of 86 recalls for cosmetics and quasi-drugs throughout 2023, shedding light on critical issues within the industry. Among the recalls, labeling discrepancies and irregular ingredients emerged as primary concerns, prompting action to address these deficiencies. Specifically, incorrect or missing labels, foreign matter contamination, and unauthorised ingredients were notable reasons for the recalls.
Recalled Cosmetics and Quasi-drugsIn 2023, a total of 64 cosmetics and 22 quasi-drugs were recalled, comprising 154 related products. The majority of these recalls fell under Class II, indicating potential risks ranging from temporary health damage to situations unlikely to cause serious harm. For cosmetics, inadequate labelling accounted for 69% of recalls, with ingredient information and product sales names being common non-compliance issues. Similarly, quasi-drug recalls were primarily attributed to ingredient problems (50%), followed by labeling issues (23%).
Addressing Labeling ConcernsNearly half of the recalled cosmetics stemmed from non-compliant labelling, notably due to incomplete or inaccurate ingredient listings. Stakeholders are advised to consult the "List of Cosmetic Ingredient Label Names" provided by the Japan Cosmetic Industry Association (JCIA) for standardised Japanese ingredient names, ensuring regulatory compliance.
Regulatory Compliance MeasuresIn Japan, cosmetics and quasi-drug ingredients are governed by positive and negative lists outlined in the Standards for Cosmetics. Adhering to these regulations prevents the use of prohibited ingredients and ensures compliance with permitted quantity limits. Quasi-drug ingredients undergo stringent approval processes, necessitating adherence to specific standards if not listed.
Imported Product RequirementsImported cosmetics and quasi-drugs require a Marketing License, with additional Manufacturing Licenses necessary for packaging, labelling, and storage activities. Compliance with these regulatory measures is essential for ensuring product safety and integrity in the Japanese market.
By addressing labelling discrepancies and adhering to regulatory standards, stakeholders can enhance consumer safety and bolster trust in cosmetic and quasi-drug products within Japan's stringent regulatory framework.
Infinity Unveils Revolutionary Fully Automatic Secondary Pouches Packaging Machine for Cosmetics Industry
Infinity, a leading innovator in packaging solutions, has recently unveiled its groundbreaking fully automatic secondary pouches packaging machine tailored specifically for the cosmetics industry. This cutting-edge technology is poised to revolutionise production processes, elevate efficiency, and set new standards in cosmetics packaging.
The cosmetics industry is renowned for its dynamic nature and ever-changing consumer preferences, necessitating packaging solutions that are not only efficient but also adaptable to market demands. Infinity's latest offering, the fully automatic secondary pouches packaging machine, is meticulously designed to meet these evolving requirements head-on.
Distinguished by its state-of-the-art features, this machine stands out from traditional packaging systems with its fully automatic operation, significantly reducing the need for manual intervention. This reduction minimises the risk of errors while maximising output—an invaluable asset in an industry where precision and consistency are paramount.
A standout feature of Infinity's secondary pouches packaging machine is its remarkable versatility. Capable of accommodating a wide array of pouch sizes, shapes, and materials, it empowers cosmetics manufacturers to package their products in alignment with their brand identity and marketing objectives. Moreover, the machine's compatibility with various closure mechanisms, such as zippers, spouts, and seals, further amplifies its flexibility.
In addition to its functionality, Infinity places a strong emphasis on sustainability in the design of this packaging machine. By optimising material usage and minimising waste, it aligns seamlessly with the growing eco-consciousness prevalent in both consumer preferences and business practices within the cosmetics industry. This commitment to sustainability not only demonstrates environmental responsibility but also yields economic benefits by reducing packaging material costs and waste disposal expenses.
The introduction of Infinity's fully automatic secondary pouches packaging machine represents a significant milestone in packaging technology evolution within the cosmetics sector. Its fusion of automation, versatility, and sustainability positions it as a game-changer for cosmetics manufacturers aiming to maintain a competitive edge in the market. Ultimately, Infinity's latest innovation signifies a paradigm shift in cosmetics packaging, offering unmatched efficiency, adaptability, and sustainability—a trifecta essential for meeting and surpassing consumer expectations while minimising environmental impact.
American Academy of Dermatology Issues New Acne Treatment Guidelines
The American Academy of Dermatology (AAD) has recently released updated guidelines aimed at enhancing the management of acne vulgaris, a prevalent dermatological concern affecting millions of individuals annually in the United States, particularly adolescents undergoing puberty. These guidelines, meticulously curated by the AAD's Acne Guideline Workgroup and published in the esteemed Journal of the American Academy of Dermatology, represent a comprehensive effort to offer evidence-based recommendations for the treatment of acne across diverse age groups, ranging from children over the age of nine to adults.
Led by board-certified dermatologist John S. Barbieri, who serves as the co-chair of the AAD's Acne Guideline Workgroup, the updated recommendations aim to build upon the foundation laid by the previous 2016 AAD acne guidelines. Barbieri emphasises the significance of these updates, particularly highlighting the incorporation of discussions on novel topical medications and systemic treatments. The inclusion of these new therapeutic modalities is anticipated to provide dermatologists and healthcare practitioners with contemporary insights into managing acne effectively, thereby ensuring optimal patient outcomes.
Acne, characterised by its multifactorial etiology and varied clinical presentations, poses a considerable challenge to healthcare providers. With nearly 50 million Americans afflicted by this condition annually, the demand for safe, efficacious, and evidence-based treatments is palpable. To address this need, the AAD's updated guidelines delineate 18 evidence-based recommendations spanning topical, systemic, and physical treatment modalities.
Among the favoured treatments endorsed by the AAD are topical benzoyl peroxide and retinoids, oral antibiotics, and their combinations. Topical benzoyl peroxide, renowned for its bactericidal properties, effectively targets acne-causing bacteria, while topical retinoids mitigate inflammation and unclog pores. Similarly, oral antibiotics, such as doxycycline, complement their topical counterparts by exerting antimicrobial effects and reducing inflammation.
Furthermore, the guidelines offer conditional recommendations for various treatments, including topical clascoterone, salicylic acid, azelaic acid, and hormonal therapies. These treatments, deemed suitable for the majority of patients, cater to individualised considerations and preferences. For instance, topical clascoterone, an emerging option, addresses hormonal acne etiology, while salicylic acid and azelaic acid offer benefits in pore decongestion and inflammation reduction.
Importantly, the guidelines underscore the significance of adopting a multimodal treatment approach to optimise therapeutic outcomes. To mitigate the risk of antibiotic resistance, the AAD advocates for the judicious use of oral antibiotics in conjunction with benzoyl peroxide. Additionally, injectable corticosteroids are recommended for expedited relief of pain and inflammation associated with larger acne lesions, while isotretinoin remains a cornerstone therapy for severe or recalcitrant cases.
Despite the plethora of treatment options outlined in the guidelines, the AAD acknowledges the paucity of evidence surrounding certain procedures and therapies, including chemical peels, light- and laser-based devices, micro-needling, dietary modifications, and alternative therapies. Moreover, caution is advised against combining certain treatments, such as broadband light or intense pulsed light with 0.3% adapalene gel, due to potential adverse effects.
Consumer Exposure to Fragrance Chemicals Are Within Safety Limits, Study Affirms
A recent collaborative study between the Research Institute for Fragrance Materials (RIFM) and Creme Global has shed light on consumer exposure to fragrance chemicals, affirming that exposure levels remain well within safety limits. Published in Regulatory Toxicology and Pharmacology on ScienceDirect, the study examined the exposure levels of approximately 3,000 fragrance-producing ingredients across various product types and routes of exposure. Lead author Dr. Isabelle Lee, senior scientist of dermatotoxicology at RIFM, notes that 76% of these ingredients fall below their threshold of toxicological concern (TTC) levels for systemic exposure, with 99% below inhalation exposure TTC levels. Co-author Dr. Anne Marie Api, RIFM’s president, emphasises the sensitivity of the human olfactory sense, which can detect fragrances at concentrations as low as parts per million or even billion. The study utilised the Creme-RIFM Aggregate Exposure model to assess exposure across oral, inhalation, and dermal routes, revealing that exposure levels were consistently below safety thresholds across product categories. While household and air care products exhibited the lowest fragrance exposure levels, oral and cosmetic/personal care products showed slightly higher exposures, still well within safety limits. Although environmental exposure was not addressed in the study, it underscores the minimal environmental impact of fragrance materials globally. Overall, the findings confirm the safety of fragrance ingredients in consumer products, contrasting with previous concerns raised by organisations like the Environmental Working Group regarding the health risks of household cleaning products containing volatile organic compounds.
Semi-permanent Gel Polish: A Regulatory Challenge
The emergence of semi-permanent gel polish has revolutionised the nail industry over the past decade, challenging the dominance of traditional nail polish. Offering durability and extended wear lasting several weeks, semi-permanent gel polish has quickly gained popularity among consumers, with one in two now opting for this option compared to just one in four five years ago.
The technology behind semi-permanent gel polish relies on cross-linking technology, utilising ingredients such as HEMA and/or Di-HEMA, and requiring UV or LED lamps for polymerisation. This process creates a strong, shiny film with a chemical bond to the natural nail, ensuring enhanced resistance to chipping.
Despite its success, the semi-permanent gel category faces challenges, including the retail sale of products intended for professional use, often evading regulations. Additionally, the market is flooded with Asian-origin products, raising concerns about unauthorised raw materials and regulatory compliance. Misleading labelling practices further compound the issue, leading to consumer disappointment and impacting the category's potential.
To address these challenges, industry experts emphasise the importance of regulatory compliance to ensure product quality and safety. Strengthened law enforcement and market withdrawals of non-compliant products are expected to follow.
IL Cosmetics Group, Europe's leading player in long-lasting nail polish, has responded to these challenges with innovation. Their HEMA-free, Di-HEMA-free semi-permanent gel polish meets European regulations while offering superior performance. These formulations, developed through years of internal research and collaboration, provide chip-free wear for up to 15 days, offering consumers a durable alternative without compromising safety or quality.
EU to Charge Cosmetics Manufacturers for Microplastic Cleanup
The European Union is proposing a regulation that would mandate cosmetics manufacturers to foot approximately 80 percent of the bill for combating microplastic pollution. As outlined by The Guardian, the regulation would necessitate governments to monitor sewage for microplastics, PFAS, and other micropollutants. The remaining 20 percent of the cleanup costs would be covered by each nation's government, with the aim of minimizing the impact on product affordability.Termed the 'polluter pays' principle, the proposed law aims to safeguard public health by ensuring a clean water supply through mitigating microplastic pollution.
